Hou et al. reported that YTHDF2 acted as a “rheostat”, and its reduction triggered inflammation reactions and vascular hyperplasia in hepatocellular carcinoma (HCC) [26]. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.